Literature DB >> 34688414

Approach to the Patient with an Incidental Adrenal Mass.

Xin He1, Patricia R Peter2, Richard J Auchus3.   

Abstract

Adrenal masses are frequently incidentally identified from cross-sectional imaging studies, which are performed for other reasons. The intensity of the approach to the patient with such a mass is tailored to the clinical situation, ranging from a quick evaluation to a detailed work-up. In all cases, the three components of the evaluation are clinical assessment, review of the images, and biochemical testing with the goal of ruling out malignancy and identifying hormonally active lesions. This article incorporates recent information to produce a logical, systematic assessment of these patients with risk stratification and proportionate follow-up.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoma; Adrenal; Aldosterone; Cortisol; Hypertension; Pheochromocytoma

Mesh:

Substances:

Year:  2021        PMID: 34688414      PMCID: PMC8984966          DOI: 10.1016/j.mcna.2021.06.009

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  62 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 2.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?

Authors:  Cristina Eller-Vainicher; Valentina Morelli; Antonio Stefano Salcuni; Massimo Torlontano; Francesca Coletti; Laura Iorio; Antonello Cuttitta; Angelo Ambrosio; Leonardo Vicentini; Vincenzo Carnevale; Paolo Beck-Peccoz; Maura Arosio; Bruno Ambrosi; Alfredo Scillitani; Iacopo Chiodini
Journal:  Eur J Endocrinol       Date:  2009-10-01       Impact factor: 6.664

4.  Diagnostic performance of unenhanced computed tomography and 18 F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours.

Authors:  Danae A Delivanis; Irina Bancos; Thomas D Atwell; Grant D Schmit; Patrick W Eiken; Neena Natt; Dana Erickson; Spyridoula Maraka; William F Young; Mark A Nathan
Journal:  Clin Endocrinol (Oxf)       Date:  2017-09-05       Impact factor: 3.478

5.  Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

Authors:  Iacopo Chiodini; Valentina Morelli; Antonio Stefano Salcuni; Cristina Eller-Vainicher; Massimo Torlontano; Francesca Coletti; Laura Iorio; Antonello Cuttitta; Angelo Ambrosio; Leonardo Vicentini; Fabio Pellegrini; Massimiliano Copetti; Paolo Beck-Peccoz; Maura Arosio; Bruno Ambrosi; Vincenzo Trischitta; Alfredo Scillitani
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

Review 6.  Medical Management of Cushing's Syndrome: Current and Emerging Treatments.

Authors:  José Miguel Hinojosa-Amaya; Daniel Cuevas-Ramos; Maria Fleseriu
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

7.  Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.

Authors:  Matthew J Brady; John Thomas; Terence Z Wong; Kendra M Franklin; Lisa M Ho; Erik K Paulson
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

8.  Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.

Authors:  Valentina Morelli; Giuseppe Reimondo; Roberta Giordano; Silvia Della Casa; Caterina Policola; Serena Palmieri; Antonio S Salcuni; Alessia Dolci; Marco Mendola; Maura Arosio; Bruno Ambrosi; Alfredo Scillitani; Ezio Ghigo; Paolo Beck-Peccoz; Massimo Terzolo; Iacopo Chiodini
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

9.  Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Authors:  T J Cawood; P J Hunt; D O'Shea; D Cole; S Soule
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

10.  Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.

Authors:  Elaine M Caoili; Melvyn Korobkin; Richard K J Brown; Gavin Mackie; Barry L Shulkin
Journal:  Acad Radiol       Date:  2007-04       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.